Forum for Intellectual Property

Policy Center

Stay Informed
Forum

Forum for Intellectual Property

Ezra Bailey/Getty Images
Caption
Ezra Bailey/Getty Images
Jonathan M. Barnett
Contributor, Forum for Intellectual Property, Hudson Institute
Jonathan M. Barnett
Reports
2 Min Read
Medical laboratory scientist, Aniela Sobel, tests serology samples from the Novavax phase 3 Covid-19 clinical vaccine trial at the UW Medicine Retrovirology Research Lab at Harborview Medical Center on February 12 (Photo by Karen Ducey/Getty Images)
Caption
Medical laboratory scientist, Aniela Sobel, tests serology samples from the Novavax phase 3 Covid-19 clinical vaccine trial at the UW Medicine Retrovirology Research Lab at Harborview Medical Center on February 12 (Photo by Karen Ducey/Getty Images)
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
Commentary
4 Min Read
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
Caption
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
Commentary
1 Min Read